Market Overview

UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on West Pharmaceutical Services

Related WST
West Receives 510(k) Clearance For NovaGuard SA Safety System
West Pharmaceutical Services Warns On FY14, CEO To Retire

In a report published Monday, Jefferies & Company reiterated its Hold rating on West Pharmaceutical Services (NYSE: WST), and raised its price target from $45.00 to $49.00.

Jefferies noted, “WST continues to see progress in shifting customers to high value (and higher margin) packaging products. The company has also benefited from accelerated demand from clients, who are building inventory and launching new products. We expected that to moderate sooner than now, but still expect it to diminish in the future. We are raising EPS based on the recent performance, while maintaining future growth rates.”

West Pharmaceutical Services closed on Friday at $52.66.

Latest Ratings for WST

Jan 2016Janney CapitalInitiates Coverage onBuy
Feb 2015JefferiesMaintainsHold
Nov 2014JefferiesMaintainsHold

View More Analyst Ratings for WST
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings


Related Articles (WST)

Get Benzinga's Newsletters